{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:22:22Z","timestamp":1789730542956,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013077","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2017YFA0205400"],"award-info":[{"award-number":["2017YFA0205400"]}],"id":[{"id":"10.13039\/501100013077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773667"],"award-info":[{"award-number":["81773667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573369"],"award-info":[{"award-number":["81573369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010896","name":"International Cooperation and Exchanges","doi-asserted-by":"publisher","award":["81811540416"],"award-info":[{"award-number":["81811540416"]}],"id":[{"id":"10.13039\/501100010896","id-type":"DOI","asserted-by":"publisher"}]},{"name":"First-class Project","award":["CPU2018GY06"],"award-info":[{"award-number":["CPU2018GY06"]}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003512","name":"State Administration of Foreign Experts Affairs of China","doi-asserted-by":"publisher","award":["B16046"],"award-info":[{"award-number":["B16046"]}],"id":[{"id":"10.13039\/501100003512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.biomaterials.2019.119616","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T23:31:27Z","timestamp":1575588687000},"page":"119616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"special_numbering":"C","title":["Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy"],"prefix":"10.1016","volume":"230","author":[{"given":"Qian-Qian","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Bin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu-Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2019.119616_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Ann. Rev. Pathol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.biomaterials.2019.119616_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2019.119616_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib6","first-page":"303","article-title":"Hepatoprotective and anti-fibrotic agents: it's time to take the next step","volume":"6","author":"Weiskirchen","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1517\/13543784.2015.1057568","article-title":"Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis","volume":"24","author":"Jaroszewicz","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.biomaterials.2019.119616_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/j.gastro.2008.12.028","article-title":"Liver fibrosis: challenges of the new era","volume":"136","author":"Wells","year":"2009","journal-title":"Gastroenterol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib9","doi-asserted-by":"crossref","first-page":"67650","DOI":"10.18632\/oncotarget.11767","article-title":"Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?","volume":"7","author":"Qu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2019.119616_bib10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s11095-013-1191-4","article-title":"Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors","volume":"31","author":"Jesson","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2019.119616_bib11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/1440-1681.12286","article-title":"Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight","volume":"41","author":"Shiha","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","article-title":"Inhibition of PDGF, TGF-\u03b2, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist nilotinib","volume":"55","author":"Liu","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib13","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.bbamcr.2013.02.033","article-title":"Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells viainhibition of histone deacetylases","volume":"1833","author":"Shaker","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biomaterials.2019.119616_bib14","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.e13551","article-title":"Comparable pharmacokinetics of 85 mg RightSize nilotinib (XS003) and 150 mg Tasigna in healthy volunteers using a hybrid nanoparticle-based formulation platform for protein kinase inhibitors","volume":"32","author":"Andersson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2019.119616_bib17","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib18","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.3748\/wjg.v20.i23.7242","article-title":"Nanotechnology applications for the therapy of liver fibrosis","volume":"20","author":"Giannitrapani","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jhep.2011.05.039","article-title":"Nanotechnology for therapy and imaging of liver diseases","volume":"55","author":"Reddy","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1746.2011.07007.x","article-title":"Retinoic acids and hepatic stellate cells in liver disease","volume":"27","author":"Lee","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib22","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1021\/nn505166x","article-title":"Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2019.119616_bib23","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/smll.201402870","article-title":"The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension","volume":"11","author":"Duong","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2019.119616_bib24","doi-asserted-by":"crossref","first-page":"1706332","DOI":"10.1002\/adfm.201706332","article-title":"Organic\u2013inorganic hybrid hollow nanoparticles suppress oxidative stress and repair damaged tissues for treatment of hepatic fibrosis","volume":"28","author":"Hayashi","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2019.119616_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","article-title":"Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis","volume":"283","author":"Qiao","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119616_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119616_bib27","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(10)63588-3","article-title":"162 progressive matrix crosslinking limits reversibility of liver fibrosis and is independent of tissue transglutaminase","volume":"138","author":"Popov","year":"2010","journal-title":"Gastroenterol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.biomaterials.2019.119616_bib29","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/acs.nanolett.6b00820","article-title":"Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy","volume":"16","author":"Zhou","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2019.119616_bib30","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/nn502807n","article-title":"Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix","volume":"8","author":"Parodi","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2019.119616_bib31","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/anie.201800511","article-title":"Semiconducting polymer nanoenzymes with photothermic activity for enhanced cancer therapy","volume":"57","author":"Li","year":"2018","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2019.119616_bib32","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1074\/jbc.R113.451211","article-title":"Interstitial collagen catabolism","volume":"288","author":"Fields","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biomaterials.2019.119616_bib33","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cub.2012.04.012","article-title":"Single-molecule tracking of collagenase on native type I collagen fibrils reveals degradation mechanism","volume":"22","author":"Sarkar","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biomaterials.2019.119616_bib34","doi-asserted-by":"crossref","first-page":"1806708","DOI":"10.1002\/adfm.201806708","article-title":"Modulation of intracellular oxygen pressure by dual - drug nanoparticles to enhance photodynamic therapy","volume":"29","author":"Fan","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2019.119616_bib35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1039\/C7PY00024C","article-title":"Aerosol delivery of biocompatible dihydroergotamine-loaded PLGA-PSPE polymeric micelles for efficient lung cancer therapy","volume":"8","author":"Qiao","year":"2017","journal-title":"Polym. Chem."},{"key":"10.1016\/j.biomaterials.2019.119616_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2014.11.014","article-title":"A novel potential biocompatible hyperbranched polyspermine for efficient lung cancer genetherapy","volume":"478","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119616_bib37","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1039\/C6PY01703G","article-title":"Histone-inspired biomimetic polymeric gene vehicles with excellent biocompatibility and enhanced transfection efficacy","volume":"7","author":"Cui","year":"2016","journal-title":"Polym. Chem."},{"key":"10.1016\/j.biomaterials.2019.119616_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translationalaspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121930715X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121930715X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:51:45Z","timestamp":1758905505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121930715X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"alternative-id":["S014296121930715X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119616","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119616"}}